Latest Tyrosine kinase receptors Stories
Two sets of gene expression profiles predict response to a common lung cancer drug for patients that have no guiding indicators for their treatment now.
Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers.
For women with aggressive early-stage breast cancer (HER2-positive disease), trastuzumab (Herceptin) given for one year after chemotherapy proved to put the women at significantly less risk of the cancer returning.
Mice previously exposed to traumatic situations demonstrate a more persistent memory of fear conditioning - acquired by associating an acoustic stimulus with an aversive stimulus - and lack the ability to inhibit this fear.
Implications for blocking metastasis and improving responses to existing therapies.
SAN DIEGO, Dec. 7, 2010 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc.
Scientists believe they may have found a new target for treating triple negative breast cancer â€“ one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.
PRINCETON, N.J., Oct.
Circulating tumor cells (CTCs) may be a promising alternative, noninvasive source of tumor materials for biomarker assessment.
Molecularly targeted therapies can reduce tumors rapidly.
- In medieval musical notation, a sign or neume denoting a shake or trill.